Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase

Onconase is a ribonuclease that presents both antitumor and antiviral properties linked to its ribonucleolytic activity and represents a new class of RNA-damaging drugs. It has reached clinical trials for the treatment of several cancers and human papilloma virus warts. Onconase targets different RN...

Descripción completa

Detalles Bibliográficos
Autores principales: Vert, Anna, Castro, Jessica, Ribó, Marc, Benito, Antoni, Vilanova, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355296/
https://www.ncbi.nlm.nih.gov/pubmed/28035074
http://dx.doi.org/10.18632/oncotarget.14302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355296/
https://www.ncbi.nlm.nih.gov/pubmed/28035074
http://dx.doi.org/10.18632/oncotarget.14302

Ejemplares similares